The inhibitory effect of diarylpropionitrile, a selective agonist of estrogen receptor beta, on the growth of MC38 colon cancer line
Authors:
- Ewelina MotylewskaEMEwelina Motylewska
- Olga StasikowskaOSOlga Stasikowska
- Gabriela Mełeń-MuchaGMGabriela Mełeń-Mucha
- 1 April 2009
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 276 (1) , 68-73
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Age, sex and the risk of grade-specific second primary colorectal cancer: Evidence for the protective effect of female hormoneEuropean Journal of Cancer, 2007
- New developments in oestrogen signalling in colonic epitheliumBiochemical Society Transactions, 2006
- ERβ is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle componentsEndocrine-Related Cancer, 2005
- The Price Tag on Progress — Chemotherapy for Colorectal CancerNew England Journal of Medicine, 2004
- Oestrogen receptor beta (ERβ) is abundantly expressed in normal colonic mucosa, but declines in colon adenocarcinoma paralleling the tumour's dedifferentiationEuropean Journal of Cancer, 2003
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002
- Estrogen metabolism in human colorectal cancer cellsThe Journal of Steroid Biochemistry and Molecular Biology, 2002
- Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysisThe American Journal of Medicine, 1999
- Sex differences in the incidence of colorectal cancer: an exploration of oestrogen and progesterone receptors.Gut, 1993
- Reproductive factors and colon cancersBritish Journal of Cancer, 1990